Evidence map›Paper›PMID 41269206›Full record

Trial reportThe New England journal of medicine2026

Medical Management and Revascularization for Asymptomatic Carotid Stenosis.

Thomas G Brott, George Howard, Brajesh K Lal, Jenifer H Voeks, Tanya N Turan, Gary S Roubin, Ronald M Lazar, Robert D Brown, John Huston, Lloyd J Edwards and 35 more

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter StudyComparative Study
In one paragraph

Trial report in The New England journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02089217 (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial), which is not on this map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02089217 nacompletednot on this map

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

TypeinterventionalSponsorMayo ClinicRan2014 to 2025Enrolled2,486ConditionsCarotid StenosisArmsCarotid endarterectomy (CEA), Carotid Stenting (CAS), Intensive Medical Management - no CEA, Intensive Medical Management - no CAS
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. The evolving landscape of stroke interventions.Singapore medical journal · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Visual electrophysiology in carotid endarterectomy: a systematic review.International journal of retina and vitreous · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors.

Thomas G BrottDepartment of Neurology, Mayo Clinic, Jacksonville, FL.
George HowardDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham.
Brajesh K LalDepartment of Surgery, University of Maryland, Baltimore.
Jenifer H VoeksDepartment of Neurology, Medical University of South Carolina, Charleston.
Tanya N TuranDepartment of Neurology, Medical University of South Carolina, Charleston.
Gary S RoubinCREST-2 executive committee, Jackson, WY.
Ronald M LazarDepartment of Neurology, University of Alabama at Birmingham, Birmingham.
Robert D BrownDepartment of Neurology, Mayo Clinic, Rochester, MN.
John HustonDepartment of Radiology, Mayo Clinic, Rochester, MN.
Lloyd J EdwardsDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham.
Michael JonesDepartment of Cardiology, Baptist Health Lexington, Lexington, KY.
Wayne M ClarkDepartment of Neurology, Oregon Health and Science University, Portland.
Ángel ChamorroDepartment of Neurology, Hospital Clinic Barcelona, Barcelona.
Laura LlullDepartment of Neurology, Hospital Clinic Barcelona, Barcelona.
Carlos Mena-HurtadoDepartment of Cardiovascular Medicine, Yale University, New Haven, CT.ORCID 0000-0002-4954-5672
Donald HeckDepartment of Radiology, Novant Health, Winston-Salem, NC.
Randolph S MarshallDepartment of Neurology, Columbia University Irving Medical Center, New York.
Virginia J HowardDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham.
Wesley S MooreDepartment of Surgery, University of California, Los Angeles, Los Angeles.
Kevin M BarrettDepartment of Neurology, Mayo Clinic, Jacksonville, FL.
Bart M DemaerschalkDepartment of Neurology, Mayo Clinic, Scottsdale, AZ.
Navdeep SanghaDepartment of Neurology, Kaiser Permanente Los Angeles Medical Center, Los Angeles.
Herbert AronowDivision of Cardiovascular Medicine, Henry Ford Hospital, Detroit.
Malcolm FosterDepartment of Interventional Cardiology, Tennova Healthcare Turkey Creek Medical Center, Knoxville, TN.
W Charles SternberghDepartment of Vascular Surgery, Ochsner Health, New Orleans.
Fayaz ShawlDepartment of Interventional Cardiology, White Oak Medical Center, Silver Spring, MD.
Giuseppe LanzinoDepartment of Neurosurgery, Mayo Clinic, Rochester, MN.
Joseph RappDepartment of Surgery, University of California, San Francisco, San Francisco.
Hoang S TranDepartment of Vascular Surgery, Deaconess Heart Group, Newburgh, IN.
Robert EckerDepartment of Neurological Surgery, MaineHealth Neurosurgery and Spine, Scarborough, ME.
Ariane MackeyDepartment of Neurology, Centre Hospitalier Universitaire de Québec, Université Laval, Quebec, QC, Canada.
Vaqar AliFirst Coast Cardiovascular Institute, Jacksonville, FL.
Curtis GivenDepartment of Neuroradiology, Baptist Health Lexington, Lexington, KY.
Philip TealDepartment of Neurology, Vancouver General Hospital, Vancouver, BC, Canada.
Vikram S KashyapDepartment of Vascular Surgery, Corewell Health, Grand Rapids, MI.ORCID 0000-0003-1780-979X
Dipankar MukherjeeDepartment of Vascular Surgery, Inova Fairfax Hospital, Falls Church, VA.
Mark HarriganDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham.
Scott SilvermanDepartment of Neurology, Massachusetts General Hospital, Boston.
Matthew KoopmannDepartment of Vascular Surgery, Oregon Health and Science University, Portland.ORCID 0000-0002-3551-797X
Virginia G WadleyDepartment of Medicine, University of Alabama at Birmingham, Birmingham.
Yu ZhangDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham.
J David RhodesDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham.
Seemant ChaturvediDepartment of Neurology, University of Maryland, Baltimore.
James F MeschiaDepartment of Neurology, Mayo Clinic, Jacksonville, FL.
CREST-2 Investigators

Funding

CREST-2 Clinical Coordinating CenterU01NS080168 · NINDS · MAYO CLINIC JACKSONVILLE · PI Thomas G Brott, JAMES F MESCHIA · 2014 to 2026
$56.3M
NSTN National Clinical Coordinating CenterU01NS086872 · NINDS · UNIVERSITY OF CINCINNATI · PI Joseph Paul Broderick, Pooja Khatri · 2013 to 2026
$32.3M
CREST-2 Statistical and Data Coordinating Center - SDCCU01NS080165 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI EDWARDS, LLOYD J · 2014 to 2025
$15.0M
NIH HHS U01 NS086872NINDS NIH HHS U01 NS080165NINDS NIH HHS U01NS080165NINDS NIH HHS U01 NS080168NINDS NIH HHS U01NS080168NINDS NIH HHS U01 NS086872RRD VA IK2 RX003798
6 · The paper itself

Abstract

backgroundImprovements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding revascularization to intensive medical management would provide greater benefit than intensive medical management alone is unclear.

methodsWe conducted two parallel, observer-blinded clinical trials that enrolled patients with high-grade (≥70%) asymptomatic carotid stenosis across 155 centers in five countries. The stenting trial compared intensive medical management alone (medical-therapy group) with carotid-artery stenting plus intensive medical management (stenting group); the endarterectomy trial compared intensive medical management alone (medical-therapy group) with carotid endarterectomy plus intensive medical management (endarterectomy group). The primary outcome was a composite of any stroke or death, assessed from randomization to 44 days, or ipsilateral ischemic stroke, assessed during the remaining follow-up period up to 4 years.

resultsA total of 1245 patients underwent randomization in the stenting trial and 1240 in the endarterectomy trial. In the stenting trial, the 4-year incidence of primary-outcome events was 6.0% (95% confidence interval [CI], 3.8 to 8.3) in the medical-therapy group and 2.8% (95% CI, 1.5 to 4.3) in the stenting group (P = 0.02 for the absolute difference). In the endarterectomy trial, the 4-year incidence of primary-outcome events was 5.3% (95% CI, 3.3 to 7.4) in the medical-therapy group and 3.7% (95% CI, 2.1 to 5.5) in the endarterectomy group (P = 0.24 for the absolute difference). From day 0 to 44, in the stenting trial, no strokes or deaths occurred in the medical-therapy group and seven strokes and one death occurred in the stenting group; in the endarterectomy trial, three strokes occurred in the medical-therapy group and nine strokes occurred in the endarterectomy group.

conclusionsAmong patients with high-grade stenosis without recent symptoms, the addition of stenting led to a lower risk of a composite of perioperative stroke or death or ipsilateral stroke within 4 years than intensive medical management alone. Carotid endarterectomy did not lead to a significant benefit. (Funded by the National Institute of Neurological Disorders and Stroke and others; CREST-2 ClinicalTrials.gov number, NCT02089217.).

Indexed as

Carotid StenosisEndarterectomy, CarotidStentsStrokeAgedAsymptomatic DiseasesCarotid ArteriesCombined Modality TherapyFemaleFollow-Up StudiesHumansKaplan-Meier EstimateMaleMiddle AgedSingle-Blind MethodTreatment Outcome

Identifiers

PMID41269206
PMCPMC13148431

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.